In this study, we provided the novel evidence that host EphA4 deficiency inhibited murine breast cancer growth and metastasis by reducing the EphA4‐GH receptor (GHR)‐IGF1 and/or EphA4‐IGF1 activities, which lead to decreasing IGF1 production. The gene discussed is GHR; the disease is breast carcinoma.